Clinical Trials Directory

Trials / Sponsors / Hookipa Biotech GmbH

Hookipa Biotech GmbH

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnA Study of HB-202/HB-201 With Pembrolizumab in Patients With HPV16+ Recurrent/Metastatic Oropharyngeal Cancer
Oropharyngeal Squamous Cell Carcinoma Recurrent
Phase 2 / Phase 32024-12-01
TerminatedSafety, Reactogenicity and Immunogenicity of HB-502 and HB-501 Versus Placebo in People With HIV on Suppressiv
Human Immunodeficiency Virus (HIV) Infection
Phase 12024-07-01
CompletedReal-world Study of First Line Pembrolizumab- or Nivolumab-treated HPV-positive Recurrent/Metastatic Oropharyn
Oropharyngeal Squamous Cell Carcinoma
—2024-06-05
TerminatedHB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer
Prostate Cancer Metastatic
Phase 1 / Phase 22023-05-23
TerminatedA Study HB-201 in Patients With Newly Diagnosed HPV16+ Oropharynx or Locally Advanced Cervical Cancer
HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer
EARLY_Phase 12021-07-28
CompletedA Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other
HPV-Related Squamous Cell Carcinoma
Phase 1 / Phase 22019-12-11
CompletedA Study of CMV Vaccine (HB-101) in Kidney Transplant Patients
Cytomegalovirus (CMV) Infection, Kidney Transplantation
Phase 22018-12-12
CompletedTrial to Evaluate Safety and Immunogenicity of a Vaccine Against HCMV
Cytomegalovirus Infection
Phase 12016-06-01